DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glucagon (Glucagon Hydrochloride) - Current Clinical Trials

 
 



Glucagon Related Clinical Trials

Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon [Completed]

Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver [Completed]

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones [Recruiting]

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes [Completed]

Evaluate the Immunogenicity of a Novel Glucagon Formulation [Completed]

Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance [Recruiting]

Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes [Active, not recruiting]

Effectiveness and Safety of Intranasal Glucagon for Treatment of Hypoglycemia in Adults [Completed]

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia [Active, not recruiting]

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes [Withdrawn]

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons [Active, not recruiting]

Glucagon and Colonoscopy [Recruiting]

Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon [Not yet recruiting]

Closed-Loop Glucagon Administration For Hypoglycemia Treatment [Recruiting]

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) [Completed]

Mini-Dose Glucagon for Adults With Type 1 Diabetes [Not yet recruiting]

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone [Completed]

Glucagon Modulation of Ghrelin Secretion [Active, not recruiting]

Physiologic Response to Glucagon at Varying Insulin Levels [Completed]

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen´┐Ż (Novo Nordisk) in Healthy Volunteers [Completed]

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia [Completed]

Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon [Recruiting]

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia [Active, not recruiting]

Effects of Glucagon Administration on Energy Expenditure [Recruiting]

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages [Completed]

Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure [Terminated]

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine´┐Ż and Insulin (MK-0893-002) [Completed]

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency [Recruiting]

The Diagnostic Accuracy of the Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and the Hypothalamic-Pituitary-Adrenal Axis [Active, not recruiting]

Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers [Completed]

The Effect of GLP-1 on the Inhibition of Glucagon Secretion [Completed]

Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization [Withdrawn]

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus [Completed]

Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion [Active, not recruiting]

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus [Completed]

Testing State of the Art Remote Glucose Monitoring at Diabetes Camp [Completed]

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes [Active, not recruiting]

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia [Completed]

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure [Not yet recruiting]

Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes [Recruiting]

The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes [Completed]

The Role of Amylin and Glucagon in T1DM [Completed]

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes [Not yet recruiting]

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes [Not yet recruiting]

Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes [Completed]

Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes [Completed]

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) [Completed]

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM [Completed]

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus [Enrolling by invitation]

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes [Recruiting]

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects [Completed]

To Evaluate the Response to Glucagon During Hypoglycemia [Completed]

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2 [Completed]

Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes [Active, not recruiting]

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects [Completed]

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease [Active, not recruiting]

Plasma Determination of Glucagon-Like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure [Recruiting]

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes [Completed]

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia [Completed]

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure. [Completed]

Effects of Glucagon Like Peptide-1 on No-reflow [Recruiting]

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance [Not yet recruiting]

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men [Completed]

Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia [Recruiting]

Sitagliptin and Glucagon Counterregulation [Not yet recruiting]

Vildagliptin Versus Dapagliflozin on Glucagon [Not yet recruiting]

Pharmacogenetics of Ace Inhibitor-Associated Angioedema [Recruiting]

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion [Recruiting]

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM) [Completed]

[Active, not recruiting]

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus [Completed]

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects [Completed]

Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator [Active, not recruiting]

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls [Completed]

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography [Recruiting]

Effect of LIXIsenatide on the Renal System [Recruiting]

Study on Lixisenatide and Counterregulation to Hypoglycemia [Active, not recruiting]

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters [Recruiting]

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans [Recruiting]

Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals [Recruiting]

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting [Not yet recruiting]

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans [Completed]

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose [Completed]

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients [Completed]

Investigating Brown Adipose Tissue Activation in Humans [Recruiting]

Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes [Completed]

Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists [Recruiting]

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery [Completed]

The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants [Completed]

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes [Completed]

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes [Completed]

Glucagon-like Peptide (GLP) Utilization and Safety [Completed]

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans [Completed]

The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease [Recruiting]

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017